CorMatrix secures FDA IDE nod to conduct trial of Cor TRICUSPID ECM valve for pediatric and adult patients

02:09 EST 25 Jan 2019 | Compelo Medical Devices

The Cor TRICUSPID is the first cardiac valve of its kind composed of extracellular matrix or ECM. The CorMatrix ECM has been utilized extensively and successfully in other

More From BioPortfolio on "CorMatrix secures FDA IDE nod to conduct trial of Cor TRICUSPID ECM valve for pediatric and adult patients"